284 related articles for article (PubMed ID: 10227970)
1. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
Allen RL; O'Callaghan CA; McMichael AJ; Bowness P
J Immunol; 1999 May; 162(9):5045-8. PubMed ID: 10227970
[TBL] [Abstract][Full Text] [Related]
2. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Vázquez MN; López de Castro JA
Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
[TBL] [Abstract][Full Text] [Related]
3. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
Kollnberger S; Bird L; Sun MY; Retiere C; Braud VM; McMichael A; Bowness P
Arthritis Rheum; 2002 Nov; 46(11):2972-82. PubMed ID: 12428240
[TBL] [Abstract][Full Text] [Related]
4. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.
Carreno BM; Hansen TH
Eur J Immunol; 1994 Jun; 24(6):1285-92. PubMed ID: 8206088
[TBL] [Abstract][Full Text] [Related]
5. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
6. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
[TBL] [Abstract][Full Text] [Related]
7. Association with beta 2-microglobulin controls the expression of transfected human class I genes.
Rein RS; Seemann GH; Neefjes JJ; Hochstenbach FM; Stam NJ; Ploegh HL
J Immunol; 1987 Feb; 138(4):1178-83. PubMed ID: 3543123
[TBL] [Abstract][Full Text] [Related]
8. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
[TBL] [Abstract][Full Text] [Related]
9. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.
Bird LA; Peh CA; Kollnberger S; Elliott T; McMichael AJ; Bowness P
Eur J Immunol; 2003 Mar; 33(3):748-59. PubMed ID: 12616495
[TBL] [Abstract][Full Text] [Related]
10. The effect of mutant beta 2-microglobulins on the conformation of HLA-B27 detected by antibody and by CTL.
Fukazawa T; Hermann E; Edidin M; Wen J; Huang F; Kellner H; Floege J; Farahmandian D; Williams KM; Yu DT
J Immunol; 1994 Oct; 153(8):3543-50. PubMed ID: 7930576
[TBL] [Abstract][Full Text] [Related]
11. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum.
Dangoria NS; DeLay ML; Kingsbury DJ; Mear JP; Uchanska-Ziegler B; Ziegler A; Colbert RA
J Biol Chem; 2002 Jun; 277(26):23459-68. PubMed ID: 11978783
[TBL] [Abstract][Full Text] [Related]
12. HLA-B27 lacking associated beta2-microglobulin rearranges to auto-display or cross-display residues 169-181: a novel molecular mechanism for spondyloarthropathies.
Luthra-Guptasarma M; Singh B
FEBS Lett; 2004 Sep; 575(1-3):1-8. PubMed ID: 15388324
[TBL] [Abstract][Full Text] [Related]
13. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P
J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899
[TBL] [Abstract][Full Text] [Related]
14. Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface.
Malik P; Klimovitsky P; Deng LW; Boyson JE; Strominger JL
J Immunol; 2002 Oct; 169(8):4379-87. PubMed ID: 12370371
[TBL] [Abstract][Full Text] [Related]
15. HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility.
Fabian H; Huser H; Loll B; Ziegler A; Naumann D; Uchanska-Ziegler B
Arthritis Rheum; 2010 Apr; 62(4):978-87. PubMed ID: 20131248
[TBL] [Abstract][Full Text] [Related]
16. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains.
Ferrier P; Layet C; Caillol DH; Jordan BR; Lemonnier FA
J Immunol; 1985 Aug; 135(2):1281-7. PubMed ID: 2409144
[TBL] [Abstract][Full Text] [Related]
17. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
[TBL] [Abstract][Full Text] [Related]
18. Strong association of HLA-B27 heavy chain with beta 2-microglobulin.
Tran TM; Horejsí V; Weinreich S; Pla M; Breur BS; Capková J; Flieger M; Ivanyi P; Ivasková E
Hum Immunol; 2000 Dec; 61(12):1197-201. PubMed ID: 11163075
[TBL] [Abstract][Full Text] [Related]
19. The immunobiology of HLA-B27: variations on a theme.
Colbert RA
Curr Mol Med; 2004 Feb; 4(1):21-30. PubMed ID: 15011956
[TBL] [Abstract][Full Text] [Related]
20. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution.
Fabian H; Huser H; Narzi D; Misselwitz R; Loll B; Ziegler A; Böckmann RA; Uchanska-Ziegler B; Naumann D
J Mol Biol; 2008 Feb; 376(3):798-810. PubMed ID: 18178223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
